SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950124-04-005382
Filing Date
2004-11-08
Accepted
2004-11-08 06:01:13
Documents
4
Period of Report
2004-11-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v03075e8vk.htm 8-K 15641
2 EXHIBIT 2.1 v03075exv2w1.txt EX-2.1 266867
3 EXHIBIT 2.2 v03075exv2w2.txt EX-2.2 55314
4 EXHIBIT 99.1 v03075exv99w1.txt EX-99.1 12118
  Complete submission text file 0000950124-04-005382.txt   352116
Mailing Address 22026 20TH AVENUE SE, SUITE 102 BOTHELL WA 98021
Business Address 22026 2OTH AVE SE STE 102 BOTHELL WA 98021 2064879500
SONUS PHARMACEUTICALS INC (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21243 | Film No.: 041124129
SIC: 2835 In Vitro & In Vivo Diagnostic Substances